Intact Vascular Secures $38.9 Million in Series B Financing to Accelerate Development of Endovascular Dissection Repair Technology

WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that it has raised $38.9 million in a Series B venture capital financing. The funds will be used to accelerate the development and FDA approval of the company‚Äôs Tack Endovascular System. The latest round, one of the largest private medical technology financings of 2015, was led by New Enterprise Associates (NEA), with participation from Quaker Partners, H.I.G. BioVentures and other existing investors.

Click here to read the full press details.

©2020 PACT All Rights Reserved